Next Article in Journal
A Novel, Highly Potent NADPH-Dependent Cytochrome P450 Reductase from Waste Liza klunzingeri Liver
Next Article in Special Issue
Thiolactones and Δ8,9-Pregnene Steroids from the Marine-Derived Fungus Meira sp. 1210CH-42 and Their α-Glucosidase Inhibitory Activity
Previous Article in Journal
Bioprospecting of Targeted Phenolic Compounds of Dictyota dichotoma, Gongolaria barbata, Ericaria amentacea, Sargassum hornschuchii and Ellisolandia elongata from the Adriatic Sea Extracted by Two Green Methods
Previous Article in Special Issue
Noonindoles A–F: Rare Indole Diterpene Amino Acid Conjugates from a Marine-Derived Fungus, Aspergillus noonimiae CMB-M0339
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance

by
Dioni Arrieche
1,†,
Jaime R. Cabrera-Pardo
2,†,
Aurelio San-Martin
3,
Héctor Carrasco
4,* and
Lautaro Taborga
1,*
1
Laboratorio de Productos Naturales, Departamento de Química, Universidad Técnica Federico Santa María, Avenida España 1680, Valparaíso 2340000, Chile
2
Laboratorio de Química Aplicada y Sustentable (LabQAS), Departamento de Química, Universidad del Bio-Bio, Avenida Collao 1202, Concepción 4030000, Chile
3
Departamento de Ciencias y Recursos Naturales, Facultad de Ciencias Naturales, Universidad de Magallanes, Avenida Bulnes 01855, Punta Arenas 6200112, Chile
4
Grupo QBAB, Instituto de Ciencias Químicas y Aplicadas, Facultad de Ingeniería, Universidad Autónoma de Chile, Llano Subercaseaux 2801, Santiago 8900000, Chile
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2023, 21(2), 98; https://doi.org/10.3390/md21020098
Submission received: 16 December 2022 / Revised: 23 January 2023 / Accepted: 26 January 2023 / Published: 29 January 2023
(This article belongs to the Special Issue Bioactive Secondary Metabolites of Marine Fungi)

Abstract

:
Fungi are a prolific source of bioactive molecules. During the past few decades, many bioactive natural products have been isolated from marine fungi. Chile is a country with 6435 Km of coastline along the Pacific Ocean and houses a unique fungal biodiversity. This review summarizes the field of fungal natural products isolated from Antarctic and Chilean marine environments and their biological activities.

1. Introduction

Natural products (NPs) represent a rich and vast biologically relevant chemical space that remains extremely difficult to access with the current arsenal of tools in chemical synthesis [1]. NPs are characterized by enormous scaffold diversity and structural complexity. Nature, via evolution, has optimized secondary metabolites to serve pivotal biological functions, including endogenous defense mechanisms as well as interaction with other organisms [2]. Natural products-based medicines can be traced back thousands of years and still contribute to many approved drugs. Indeed, natural products and their derivatives represented 27% of all therapeutics approved by the FDA between 1981 and 2019 [3,4]. In recent years, this proportion has increased, illustrating the continued importance of NPs. Research programs focused on unveiling new NPs from understudied microorganisms, such as fungi isolated from Chilean marine environments, are crucial to the future drug development pipeline.
Fungi represent one of the largest groups of organisms. They are widely distributed across both mild and extreme ecosystems on our planet [5]. They have developed a unique metabolic plasticity, allowing them to rapidly adapt and survive through the biosynthesis of an array of fascinating natural products [6]. A recent analysis of fungal genomes has revealed many secondary metabolite pathways that can be tuned or modified, producing novel and valuable chemical scaffolds [7]. Fungal-derived natural products are pharmaceutically abundant, with several important biological applications ranging from highly potent toxins to approved drugs [8]. Since the discovery of penicillin, an antibiotic of fungal origin, many efforts around the globe have been devoted to searching for fungal-derived bioactive products. Fungi are a vast yet untapped source to search for pharmaceutically relevant molecules displaying a range of bioactivity, including anti-cancer, antioxidant, hepatoprotective, antibacterial, antidiabetic, and anti-inflammatory capabilities.
Oceans are the source of a wide variety of natural products with unique structures mainly produced by marine macro-organisms, such as invertebrates (e.g., sponges, soft corals, tunicates) and algae. Additionally, many marine natural products have proved to be pharmacologically relevant [9,10,11].
Secondary metabolites obtained from marine fungi have been particularly interesting, mainly because of their unique chemical structures and biomedical applications [8,12]. In 1949, cephalosporin C was discovered from a culture of Cephalosporium fungus species obtained from the Sardinian coast [13]. Since then, extensive efforts over decades of work have revealed the vast chemical and biological potential of marine fungal natural products. Strains of marine fungi have been obtained from practically every possible marine habitat, including inorganic, marine microbial communities, marine plants, and marine vertebrates [10]. While the number of cultivable marine fungi is extremely low (1% or less) compared to their global biodiversity [8,9,10], the number of natural products that have been isolated and characterized from marine fungi exceeds 1000 molecules [14]. These include alkaloids, lipids, peptides, polyketides, prenylated polyketides, and terpenoids [14,15,16,17].
Chile has 6435 km of coastline and exercises exclusive rights over its maritime space called the Chilean Sea. This comprises four zones: the Territorial Sea (120,827 km2), the contiguous zone (131,669 km2), the exclusive economic zone (3,681,989 km2), and that corresponding to the Continental shelf (161,338 km2) [18].
The Chilean maritime territory, in the Pacific Ocean, consists of highly structured geographic sections displaying unique features that arise from the interactions of water masses with the seabed, emerged relief, air masses and centers of atmospheric action [19]. These phenomena lead to an environment suitable for a rich biodiversity ranging from microscopic organisms that swarm the waters in incredible numbers to large fish and other organisms [20]. Along the lengthy coastline, Chilean waters also differ in terms of important characteristics, e.g., mineral and saline composition [19].
The cold waters associated with both the Humboldt and Antarctic currents are characterized by a high gas and nitrogen content, unlike in temperate and warm waters. Consequently, phytoplankton is abundant in the Chilean sea and supports the growth of various marine organisms, specifically fungi. Therefore, Chile´s coastline provides a distinct environment for fungal biodiversity to flourish [21].
Despite its importance, there are not many reports about secondary metabolites from marine fungi or marine-derived fungi in Chile. Reports included in this review cover the period from 1996 until present. In this work, we have made a comprehensive review of compounds that have been isolated and chemically characterized during this time. Their biological activities are also reported.

2. Secondary Metabolites Isolated from Chilean Marine Fungi in Continental Coasts

Studies carried out on cultures of Cladosporium cladosporioides, a fungus isolated from the marine sponge Cliona sp. collected in Region IV of Chile in 2004, led to the identification of p-methylbenzoic acid (1) and peroxyergosterol (2) (Figure 1). This was the first time that 1 had been isolated as a natural product. It was reported that peroxyergosterol from Inonotus obliquus inhibited the growth of cancer cells and showed cytotoxic effects on the same cell lines. Additionally, peroxyergosterol displayed potent inhibition of lipid peroxidation and higher antioxidant activity than well-known antioxidants, such as α-tocopherol and thiourea. A recent study also revealed inhibitory effects of peroxyergosterol on inflammation and tumor promotion in mouse skin [22]. In addition, compounds 1 and 2 did not show antimicrobial activity against Gram-positive (Staphylococcus aureus, S. epidermidis) or Gram-negative bacteria (Escherichia coli, Proteus mirabilis, Enterococcus faecalis) in the agar plate diffusion assay. Both compounds were inactive against Artemia salina [23].
Four previously reported metabolites (36, Figure 2) were isolated from Penicillium brevicompactun, collected in Quintay, Chile (region V). The mycelium and broth were extracted with ethyl acetate, and the solvent was evaporated to provide a crude extract that showed in vitro antibacterial activity against both Gram-positive (Staphylococcus aureus, S. epidermidis) and Gram-negative bacteria (Escherichia coli, Proteus mirabilis, Enterococcus faecalis and Pseudomonas aeruginosa) [24].
Four steroids (2, 79) (Figure 1 and Figure 3) were isolated from cultures of Geotrichum sp., a fungus obtained from marine sediment collected in Concepción Bay, Chile (Region VIII). Compound 7 is commonly found in fungal extracts since it plays a structural role in the cytoplasmic membrane. Similarly, 2 is a ubiquitous NP present in a variety of lichens, fungi, sponges, and marine organisms. Compound 8 has been isolated from Lampteromyces japonicus and a luminous bacterium. Additionally, 8 has been found in non-luminous basidiomycete fungi, including Fomes officinalis and Scleroderma polyrhizum. It has also been isolated from a marine sponge Dictyonella incisa [25]. This is the first time this compound has been identified in a facultative marine fungus [26].
Compound 10 is the first indole derivative isolated from a marine fungus (Cladosporium cladosorioides). The crystal structure of N-methyl-1H-indole-2-carboxamide (10) (Figure 4) was determined by single-crystal X-ray diffraction [27].
Two dibenzylbutyrolactones (11,12) (Figure 5) and two sesterterpenoids (13,14) (Figure 5) were obtained from Aspergillus sp. (2P-22) isolated from the marine sponge, Cliona chilensis collected in Los Molles, Chile (Region IV) [28]. Spectroscopic data highlighted compound 11 as a novel compound named butylrolactone-VI. All four compounds were then tested for antibacterial activity against both Gram-positive (Clavibacter michiganensis 807) and Gram-negative bacteria (Pseudomonas syringae pv syringae, Xanthomonas arboricola pv juglandis 833, Erwinia carotovora, Agrobacterium tumefaciens A348), vasorelaxant effects, and antitumor bioactivities employing a broth culture of A. tumefaciens [28].

3. Secondary Metabolites Isolated from Antarctic Marine Fungi

The Antarctic continent represents one of the most extreme environments on earth for life to exist [29]. This ecosystem is characterized by high-stress conditions, including low temperatures, scarce availability of nutrients, high acidity, and high levels of ultra-violet radiation [30]. In order to survive under these highly demanding conditions, fungi living in the Antarctic have had to adapt their biochemical machinery and have done so through modifications in gene expression as well as the biosynthesis of secondary metabolites. Thus, Antarctic fungi represent a unique, biologically relevant chemical space with tremendous potential to contribute to the development of effective therapeutics [31]. Indeed, a number of efforts have reported unique NPs isolated from fungi living in Antarctic environments [31] and this emerging field promises a vast capacity for expansion.
In cold marine ecosystems, the presence of fungi has been associated with macroalgae and invertebrates, although some species have also been recorded in seawater and sediments [32,33]. Five new asterric acid derivatives were identified and isolated from the fermentation of the Antarctic ascomycete Geomyces sp.: ethyl asterrate (15) (Figure 6), n-butyl asterrate (16) (Figure 6), and geomycins A–C (1719) (Figure 6). These compounds were evaluated for antifungal and antibacterial properties. Geomycin B (18) showed significant activity against Aspergillus fumigatus ATCC 10894, with IC50/MIC values of 0.86/29.5 µM, indicating much higher antifungal activity than the positive control fluconazole, which showed IC50/MIC values of 7.35/163.4 µM [31,34].
Six new peptaibols (linear or cyclic peptides), named asperelines A–F (2025) (Figure 7), were characterized from the fermentation of the marine-derived fungus Tridocherma asperellum collected from the sediment of the Antarctic Penguin Island. Chemical structures were determined using 1D and 2D NMR techniques as well as ESIMS/MS [35].
Next, two highly oxygenated polyketides, penylactones A and B (26 and 27) (Figure 8) were isolated and identified from Penicillium crustosum PRB-2. These compounds had a similar chemical structure but opposite absolute stereochemistry. Compounds 26 and 27 were tested for their ability to inhibit nuclear factor-κB (NF-κB) via transient transfection and reporter gene expression assays. Of the two compounds, only 27 showed inhibitory activity with a relatively weak effect of 40% inhibitory rate at a concentration of 10 µM [36]. The authors also proposed a biosynthetic pathway for both compounds, shown in Scheme 1 [36]. These penylactones are characterized by a new carbon skeleton formed from two units of 3,5-dimethyl-2,4-diol-acetophenone and γ-butyrolactone. Six compounds were subsequently synthesized through a novel biomimetic synthesis pathway, as shown in Scheme 2 [37].
A study of the Antarctic fungus Oidiodendron truncatum GW3-13 isolated two new epipolythiodioxopiperazines, chetrazins B (28) and C (29), together with five new diketopiperazines, chetracin D (30), and oidiooperazines A–D (3134) (Figure 9). In vitro studies using 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) showed that compound 28 exhibits potent biological activity in the nanomolar range against a panel of five human cancer lines (HCT-8, BEL-7402, BGC-823, A-549, and A-2780) [38].
In the same study, compounds 29 and 30 exhibited significant cytotoxicity at micromolar concentration. Finally, it was observed that compounds 3134 did not show cytotoxicity at a concentration of 10 µM. This led to the conclusion that the sulfide bridge was a determining factor in the biological activity presented by these compounds. In contrast, the number of sulfur atoms in the bridge did not seem to influence the bioactivity [38].
Organic extracts of several fungi were isolated from samples of Porifera collected on King George Island. Although pure compounds could not be isolated, the presence of biological activities and potential as antimicrobial agents could be investigated. Antimicrobial activity was tested using strains of Pseudomonas aeruginosa, Staphylococcus aureus ATCC25922, Clavibacter michiganensis 807, and Xanthomonas campestris 833. Antitumoral activity was assessed using Agrobacterium tumefaciens At348 as a model, and antioxidant activity was determined by comparing the absorbance of ascorbic acid obtained from each extract. Approximately 50% of the 101 extracts showed antibacterial activity against at least one of the bacteria tested, being more active against Gram-positive bacteria such as Staphylococcus aureus. Moreover, 43 extracts showed 50% inhibition of crown gall tumor growth on potato. Antioxidant studies revealed that 97 fungal extracts displayed decent activities varying from very low to mild, and only three isolates showed high antioxidant activities [39].
Four new compounds, namely Pseudogymnoascins A–C (3537) and 3-nitroasterric acid (38) (Figure 10), were characterized from a culture of Pseudogymnoascus sp., obtained from an Antarctic marine sponge of the genus Hymeniacidon [40]. Remarkably, these compounds were the first nitro derivatives of asterric acid identified. The antimicrobial activity of compounds 3538 was evaluated against Pseudomonas aeruginosa PAO1, Actinobacter baumannii CL5973, Escherichia coli MB2884, Staphylococcus aureus EP1167, and S. aureus MB5394. Their antifungal activity was also tested against Candida albicans MY1055, C. albicans ATCC64124, and Aspergillus fumigatus ATCC46645. Cytotoxicity against the tested microorganisms was not observed, suggesting that the presence of the nitro group in the structure may negatively influence the biological activity of these compounds [40].
One hundred fungal strains were isolated from 55 samples of maritime Antarctic and classified into 35 fungal taxa within 20 genera. Extracts from these strains were tested against human tumoral cells, parasitic protozoa (Leishmania amazonensis, Trypanosoma cruzi), fungi, and bacteria. The extracts from Purpureocillum lilacinum displayed high trypanocidal, antibacterial, and antifungal activities with moderate toxicity over normal cells [41].
In recent years the chemical compounds of Penicillium sp. S-1-18 isolated from Antarctic seabed sediments has been extensively investigated. Butanolide A (39), a new furanone derivative, and guignarderemophilane F (40), a new sesquiterpene, together with six known compounds: penicyclone A (41), xylarenone A (42), callyspongidipeptide A (43), cyclo-(L-Phe-4R-hydroxyl-L-Pro) (44), cyclo-(L-Pro-L-Phe) (45), and N-(2-hydroxy-propanoyl)-2-aminobenzoic acid amide (46), were isolated (Figure 11). The structures of these metabolites were determined using 1D- and 2D-NMR spectroscopic methods. Inhibitory effects against PTP1B activity were tested for all compounds. Only compound 39 showed activity against PTP1B, which was moderate compared with the positive control oleanolic acid [42].
An interesting study of the distribution of marine fungi found that Pseudogymnoascus sp. and species of the genus Penicillium were present in all marine samples. Samples collected at 20 m or more in depth, at temperatures near 0 °C, had higher diversity those from the intertidal zone (superficial samples) [43].
The antibacterial activity was assessed for four new compounds, Penixylarins A–D (4750), obtained from a culture of the Antarctic fungus Penicillium crustosum PRB-2 and the mangrove-derive fungus Xylaria sp. HDN12-249 (Figure 12). Compounds 48 and 49 showed antibacterial activity against B. subtilis, M. phlei, and V. parahemolyticus. Compound 49 additionally displayed potential antituberculosis effects against Mycobacterium phlei [44].
In a 2018 review, Tripathi et al. described more than two hundred natural products isolated from prokaryotes and eukaryotes living in polar regions, including fungi. Their pharmacology, relevant bioactivity, and chemical structures were reported in the review [45]. One year later, anticancer compounds were isolated from seaweed-derived endophytic fungi [46].
Using a different sampling strategy, pieces of excrement from Adelie penguins allowed the isolation of Penicillium chrysogenum. Although the sample was not collected from a marine environment per se, the feeding habits of the penguins support the idea that the microorganisms isolated are marine. The exact location of the sample collection site was not stated but is presumably near the Chinese Great Wall Antarctic base. A new compound Chrysonin (51) was obtained as a pair of enantiomers 6S- and 6R-chrysonin (51a and 51b) (Figure 13). These compounds display an eight-membered heterocycle fused with a benzene ring. Interestingly, there is no precedent of one natural compound with this structure. Compound 52 was also isolated as a mixture of a new zwitterionic compound chrysomamide (52a) and N-[2-trans-(4-hydroxyphenyl) ethenyl] formamide (52b) (Figure 13). Compound 53, shown in Figure 13, contains the unusual isocyanide functional group. This functional group has been found in several marine organisms, such as cyanobacteria, Penicillium fungi, marine sponges, and nudibranchs. Furthermore, there is no precedent of one natural compound with an eight-membered heterocycle fused with a benzene ring. Antibacterial activity of each compound against eight microorganisms was determined. Compound 53 (Figure 13) was active against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. The same metabolite and compound 54 (Figure 13) both showed significant cytotoxicity against four cancer cell lines: A. baumannii ATCC 19606, E. coli ATCC 25922, M. luteus SCSIO MLO1, and MRSA, shhs-A1. Compound 55 (Figure 13) displayed the best alpha glucosidase inhibition [47].
Penicillium echinulatum was isolated from the surface of the alga Adenocystis utricularis collected on a beach close to Comandante Ferraz Brazilian station on King George Island. In this study, photosafety was evaluated using photoreactivity (OECD TG 495) and phototoxicity assays performed by 3T3 neutral red uptake (3T3 NRU PT, OECD TG 432) and the RHS model. The purification of four alkaloids was achieved in a bio-guided process. Four known metabolites were identified: (−)-cyclopenin (56), dehydrocyclopeptine (57), viridicatin (58), and viridicatol (59) (Figure 14), and their photoprotective and antioxidant activities were shown [48].
The antibacterial activity of Penicillic acid (60) (Figure 15), isolated from Penicillium sp. CRM-1540 found in Antarctic marine sediment at King George Island, was evaluated. This compound was obtained as the major bioactive fraction through a bioguided study. Results showed 90% bacterial inhibition in vitro at 25 µg mL−1 against Xanthomonas citri [49].
Talaverrucin A (61) (Figure 16), a heterodimeric oxaphenalenone with a rare fused ring system, was isolated from Talaromyces sp. HDN151403 (Prydz Bay, Antarctica). The oncogenic Wnt/β-catecin inhibitory effect was tested and showed inhibitory activity in zebrafish embryos in vivo and cultured mammalian cells in vitro [50].
The cytotoxic activity of Citromycin (62) (Figure 17) was tested against ovarian cancer SKOV3 and A2780 cells. No cytotoxic activity was observed. The compound 62 was obtained from Sporothrix sp. and showed inhibition of extracellular signal-regulated kinase (ERK)-1/1 [51].
Four new cytotoxic nitrobenzoyl sesquiterpenoids, insulicolides D–G (6366) (Figure 18), were isolated from Aspergillus insulicola HDN151418, which was obtained from an unidentified Antarctica sponge (Prydz Bay). Compounds 65 and 66 showed selective inhibition against human PDAC cell lines [52].
Three new perylenequinone derivatives (Xanalterate A, 67, Altertoxin VIII, 68 and IX, 69) together with a known natural product, Stemphyperylenol (70) (Figure 19), were isolated from Alternaria sp. HDN19-690 associated to an Antarctic sponge. Compound 67 exhibited promising antibacterial activity against methicillin-resistant coagulase negative Staphylococcus (MRCNS), Bacillus subtilis, Proteus mirabilis, Bacillus cereus, Escherichia coli, and Mycobacterium phlei with MIC values ranging from 3.13 to 12.5 µM [53].

4. Materials and Methods

Scifinder database and the repositories of the Pontificia Universidad Católica de Chile and Universidad Técnica Federico Santa Maria were used to search for reports published from 1996 to date. The search criteria focused on marine fungi obtained from Chilean coasts, the South Shetland Islands, and Antarctic peninsula and reports of novel marine NPs that were spectroscopically characterized and presented biological or pharmaceutical properties. Descriptions involving vegetable extracts or primary metabolites were omitted.

5. Conclusions

Natural products from Chilean marine fungi represent a prolific and yet underexplored source of chemical structures with remarkable biomedical applications (Table 1). Alkaloids, polyketides, terpenoids, isoprenoids, non-isoprenoid compounds, and quinones display the most relevant biological activities. There are few studies on secondary metabolites isolated from marine fungi collected in Chile, highlighting the antimicrobial activity presented by some crude extracts and the antitumor activity of some of the isolated compounds. The dearth of studies may be attributed to the difficulties in cultivating microorganisms, some of which cannot survive under standard laboratory conditions and therefore cannot be cultured using traditional techniques. It is complicated to reproduce the conditions found inside the host marine organisms. The culture medium used is suitable for facultative fungi but probably inadequate for natural marine fungi. Recent advances in chromatographic and spectroscopic techniques now open a world of possibility for isolating secondary metabolites of these organisms that are abundant in Chilean marine ecosystems.

Author Contributions

Conceptualization, D.A. and J.R.C.-P.; writing—original draft preparation, D.A.; resources, D.A.; H.C., A.S.-M. and J.R.C.-P.; writing—review and editing, L.T., H.C., J.R.C.-P. and A.S.-M. All authors participated in similar measure in the preparation of this manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

Instituto Antártico Chileno (INACH) RT_16-21.

Acknowledgments

J.R.C.-P thanks Instituto Antártico Chileno (INACH), for grant RT_16-21, D.A express thanks to the Dirección de Postgrado y Programas (DPP), Universidad Técnica Federico Santa María. The authors thank Ellen Leffler for critical reading and suggestions.

Conflicts of Interest

The authors declare that they have no conflicting interest in the publication.

References

  1. Tong, Y.; Deng, Z. An Aurora of Natural Products-Based Drug Discovery Is Coming. Synth. Syst. Biotechnol. 2020, 5, 92–96. [Google Scholar] [CrossRef]
  2. Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016, 79, 629–661. [Google Scholar] [CrossRef] [Green Version]
  3. Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020, 83, 770–803. [Google Scholar] [CrossRef] [Green Version]
  4. Clardy, J.; Walsh, C. Lessons from Natural Molecules. Nature 2004, 432, 829–837. [Google Scholar] [CrossRef]
  5. Choi, J.; Kim, S.-H. A Genome Tree of Life for the Fungi Kingdom. Proc. Natl. Acad. Sci. USA 2017, 114, 9391–9396. [Google Scholar] [CrossRef] [Green Version]
  6. Calvo, A.M.; Wilson, R.A.; Bok, J.W.; Keller, N.P. Relationship between Secondary Metabolism and Fungal Development. Microbiol. Mol. Biol. Rev. 2002, 66, 447–459. [Google Scholar] [CrossRef] [Green Version]
  7. Nielsen, J.C.; Grijseels, S.; Prigent, S.; Ji, B.; Dainat, J.; Nielsen, K.F.; Frisvad, J.C.; Workman, M.; Nielsen, J. Global Analysis of Biosynthetic Gene Clusters Reveals Vast Potential of Secondary Metabolite Production in Penicillium Species. Nat. Microbiol. 2017, 2, 17044. [Google Scholar] [CrossRef]
  8. Schueffler, A.; Anke, T. Fungal Natural Products in Research and Development. Nat. Prod. Rep. 2014, 31, 1425–1448. [Google Scholar] [CrossRef]
  9. Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine Natural Products. Nat. Prod. Rep. 2021, 38, 362–413. [Google Scholar] [CrossRef]
  10. Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine Natural Products. Nat. Prod. Rep. 2022, 39, 1122–1171. [Google Scholar] [CrossRef]
  11. Montuori, E.; De Pascalle, D.; Lauritano, C. Recent Discoveries on Marine Organism Immunomodulatory Activities. Mar. Drugs. 2022, 20, 422. [Google Scholar] [CrossRef]
  12. Durães, F.; Szemerédi, N.; Kumla, D.; Pinto, M.; Kijjoa, A.; Spengler, G.; Sousa, E. Metabolites from Marine-Derived Fungi as Potential Antimicrobial Adjuvants. Mar. Drugs. 2021, 19, 475. [Google Scholar] [CrossRef]
  13. De la Calle, F. Fármacos de Origen Marino. Treballs de la SCB. 2007, 58, 141–155. [Google Scholar] [CrossRef]
  14. Rateb, M.E.; Ebel, R. Secondary Metabolites of Fungi from Marine Habitats. Nat. Prod. Rep. 2011, 28, 290. [Google Scholar] [CrossRef]
  15. Hafez Ghoran, S.; Kijjoa, A. Marine-Derived Compounds with Anti-Alzheimer’s Disease Activities. Mar. Drugs. 2021, 19, 410. [Google Scholar] [CrossRef]
  16. Jiang, M.; Wu, Z.; Guo, H.; Liu, L.; Chen, S. A Review of Terpenes from Marine-Derived Fungi: 2015–2019. Mar. Drugs. 2020, 18, 321. [Google Scholar] [CrossRef]
  17. El-Demerdash, A.; Kumla, D.; Kijjoa, A. Chemical Diversity and Biological Activities of Meroterpenoids from Marine Derived-Fungi: A Comprehensive Update. Mar. Drugs. 2020, 18, 317. [Google Scholar] [CrossRef]
  18. Nuestro País. Available online: https://www.gob.cl/nuestro-pais/ (accessed on 24 October 2022).
  19. Masas de Agua En El Mar Chileno. Available online: http://www7.uc.cl/sw_educ/geo_mar/html/h43.html (accessed on 24 October 2022).
  20. Biblioteca del Congreso Nacional | SIIT | Chile Nuestro País. Available online: https://www.bcn.cl/siit/nuestropais/index_html (accessed on 24 October 2022).
  21. Núñez-Pons, L.; Shilling, A.; Verde, C.; Baker, B.J.; Giordano, D. Marine Terpenoids from Polar Latitudes and Their Potential Applications in Biotechnology. Mar. Drugs 2020, 18, 401. [Google Scholar] [CrossRef]
  22. Yasukawa, K.; Akihisa, T.; Kanno, H.; Kaminaga, T.; Izumida, M.; Sakoh, T.; Tamura, T.; Takido, M. Inhibitory Effects of Sterols Isolated from Chlorella Vulgaris on 12-O-Tetradecanoylphorbol-13-Acetate-Induced Inflammation and Tumor Promotion in Mouse Skin. Biol. Pharm. Bull. 1996, 19, 573–576. [Google Scholar] [CrossRef] [Green Version]
  23. San Martin, A.; Painemal, K.; Diaz, Y.; Martinez, C.; Rovirosa, J. Metabolites from the marine fungus Cladosporium cladosporioides. J. Chil. Chem. Soc. 2005, 93, 247–251. [Google Scholar]
  24. Rovirosa, J.; Diaz-Marrero, A.; Darias, J.; Painemal, K.; San Martin, A. Secondary metabolites from the marine Penicillium brevicompactum. J. Chil. Chem. Soc. 2006, 51, 775–778. [Google Scholar] [CrossRef]
  25. Ciminiello, P.; Fattorusso, E.; Magno, S.; Mangoni, A.; Pansini, M. A Novel Conjugated Ketosteroid from the Marine Sponge Dictyonella Incisa. J. Nat. Prod. 1989, 52, 1331–1333. [Google Scholar] [CrossRef]
  26. San-Martín, A.; Orejarena, S.; Gallardo, C.; Silva, M.; Becerra, J.; Reinoso, R.; Chamy, M.C.; Vergara, K.; Rovirosa, J. Steroids from the marine fungus Geotrichum sp. J. Chil. Chem. Soc. 2008, 53, 1377–1378. [Google Scholar] [CrossRef] [Green Version]
  27. Manríquez, V.; Galdámez, A.; Veliz, B.; Rovirosa, J.; Díaz-Marrero, A.R.; Cueto, M.; Darias, J.; Martínez, C.; San-Martín, A. N-methyl-1H-indole-2-carboxamide from the marine fungus Cladosporium cladosporioides. J. Chil. Chem. Soc. 2009, 54, 314–316. [Google Scholar] [CrossRef] [Green Version]
  28. San-Martín, A.; Rovirosa, J.; Vaca, I.; Vergara, K.; Acevedo, L.; Viña, D.; Orallo, F.; Chamy, M.C. New butyrolactone from a marine-derived fungus Aspergillus sp. J. Chil. Chem. Soc. 2011, 56, 625–627. [Google Scholar] [CrossRef] [Green Version]
  29. Wilson, Z.E.; Brimble, M.A. Molecules Derived from the Extremes of Life. Nat. Prod. Rep. 2009, 26, 44–71. [Google Scholar] [CrossRef] [PubMed]
  30. Rusman, Y.; Held, B.W.; Blanchette, R.A.; He, Y.; Salomon, C.E. Cadopherone and Colomitide Polyketides from Cadophora Wood-Rot Fungi Associated with Historic Expedition Huts in Antarctica. Phytochemistry 2018, 148, 1–10. [Google Scholar] [CrossRef]
  31. Tian, Y.; Li, Y.-L.; Zhao, F.-C. Secondary Metabolites from Polar Organisms. Mar. Drugs. 2017, 15, 28. [Google Scholar] [CrossRef] [Green Version]
  32. Fungi of Antarctica: Diversity, Ecology and Biotechnological Applications; Rosa, L.H. (Ed.) Springer International Publishing: Cham, Switzerland, 2019; ISBN 978-3-030-18366-0. [Google Scholar]
  33. Cong, M.; Pang, X.; Zhao, K.; Song, Y.; Liu, Y.; Wang, J. Deep-Sea Natural Products from Extreme Environments: Cold Seeps and Hydrothermal Vents. Mar. Drugs. 2022, 20, 404. [Google Scholar] [CrossRef]
  34. Li, Y.; Sun, B.; Liu, S.; Jiang, L.; Liu, X.; Zhang, H.; Che, Y. Bioactive Asterric Acid Derivatives from the Antarctic Ascomycete Fungus Geomyces Sp. J. Nat. Prod. 2008, 71, 1643–1646. [Google Scholar] [CrossRef]
  35. Ren, J.; Xue, C.; Tian, L.; Xu, M.; Chen, J.; Deng, Z.; Proksch, P.; Lin, W. Asperelines A−F, Peptaibols from the Marine-Derived Fungus Trichoderma Asperellum. J. Nat. Prod. 2009, 72, 1036–1044. [Google Scholar] [CrossRef] [PubMed]
  36. Wu, G.; Ma, H.; Zhu, T.; Li, J.; Gu, Q.; Li, D. Penilactones A and B, Two Novel Polyketides from Antarctic Deep-Sea Derived Fungus Penicillium Crustosum PRB-2. Tetrahedron. 2012, 68, 9745–9749. [Google Scholar] [CrossRef]
  37. Spence, J.T.J.; George, J.H. Biomimetic Total Synthesis of ent-Penilactone A and Penilactone B. Org. Lett. 2013, 15, 3891–3893. [Google Scholar] [CrossRef] [PubMed]
  38. Li, L.; Li, D.; Luan, Y.; Gu, Q.; Zhu, T. Cytotoxic Metabolites from the Antarctic Psychrophilic Fungus Oidiodendron Truncatum. J. Nat. Prod. 2012, 75, 920–927. [Google Scholar] [CrossRef]
  39. Henríquez, M.; Vergara, K.; Norambuena, J.; Beiza, A.; Maza, F.; Ubilla, P.; Araya, I.; Chávez, R.; San-Martín, A.; Darias, J.; et al. Diversity of Cultivable Fungi Associated with Antarctic Marine Sponges and Screening for Their Antimicrobial, Antitumoral and Antioxidant Potential. World J. Microbiol. Biotechnol. 2014, 30, 65–76. [Google Scholar] [CrossRef]
  40. Figueroa, L.; Jiménez, C.; Rodríguez, J.; Areche, C.; Chávez, R.; Henríquez, M.; de la Cruz, M.; Díaz, C.; Segade, Y.; Vaca, I. 3-Nitroasterric Acid Derivatives from an Antarctic Sponge-Derived Pseudogymnoascus Sp. Fungus. J. Nat. Prod. 2015, 78, 919–923. [Google Scholar] [CrossRef]
  41. Gonçalves, V.N.; Carvalho, C.R.; Johann, S.; Mendes, G.; Alves, T.M.A.; Zani, C.L.; Junior, P.A.S.; Murta, S.M.F.; Romanha, A.J.; Cantrell, C.L.; et al. Antibacterial, Antifungal and Antiprotozoal Activities of Fungal Communities Present in Different Substrates from Antarctica. Polar Biol. 2015, 38, 1143–1152. [Google Scholar] [CrossRef]
  42. Zhou, Y.; Li, Y.-H.; Yu, H.-B.; Liu, X.-Y.; Lu, X.-L.; Jiao, B.-H. Furanone Derivative and Sesquiterpene from Antarctic Marine-Derived Fungus Penicillium Sp. S-1-18. J. Asian Nat. Prod. Res. 2018, 20, 1108–1115. [Google Scholar] [CrossRef]
  43. Wentzel, L.C.P.; Inforsato, F.J.; Montoya, Q.V.; Rossin, B.G.; Nascimento, N.R.; Rodrigues, A.; Sette, L.D. Fungi from Admiralty Bay (King George Island, Antarctica) Soils and Marine Sediments. Microb. Ecol. 2019, 77, 12–24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Yu, G.; Sun, Z.; Peng, J.; Zhu, M.; Che, Q.; Zhang, G.; Zhu, T.; Gu, Q.; Li, D. Secondary Metabolites Produced by Combined Culture of Penicillium crustosum and a Xylaria Sp. J. Nat. Prod. 2019, 82, 2013–2017. [Google Scholar] [CrossRef]
  45. Tripathi, V.C.; Satish, S.; Horam, S.; Raj, S.; lal, A.; Arockiaraj, J.; Pasupuleti, M.; Dikshit, D.K. Natural Products from Polar Organisms: Structural Diversity, Bioactivities and Potential Pharmaceutical Applications. Polar Sci. 2018, 18, 147–166. [Google Scholar] [CrossRef]
  46. Teixeira, T.R.; Santos, G.S.d.; Armstrong, L.; Colepicolo, P.; Debonsi, H.M. Antitumor Potential of Seaweed Derived-Endophytic Fungi. Antibiotics. 2019, 8, 205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Khan, I.; Zhang, H.; Liu, W.; Zhang, L.; Peng, F.; Chen, Y.; Zhang, Q.; Zhang, G.; Zhang, W.; Zhang, C. Identification and Bioactivity Evaluation of Secondary Metabolites from Antarctic-Derived Penicillium chrysogenum CCTCC M 2020019. RSC Adv. 2020, 10, 20738–20744. [Google Scholar] [CrossRef]
  48. Teixeira, T.R.; Rangel, K.C.; Tavares, R.S.N.; Kawakami, C.M.; dos Santos, G.S.; Maria-Engler, S.S.; Colepicolo, P.; Gaspar, L.R.; Debonsi, H.M. In Vitro Evaluation of the Photoprotective Potential of Quinolinic Alkaloids Isolated from the Antarctic Marine Fungus Penicillium echinulatum for Topical Use. Mar. Biotechnol. 2021, 23, 357–372. [Google Scholar] [CrossRef]
  49. Vieira, G.; Khalil, Z.G.; Capon, R.J.; Sette, L.D.; Ferreira, H.; Sass, D.C. Isolation and Agricultural Potential of Penicillic Acid against Citrus Canker. J. Appl. Microbiol. 2022, 132, 3081–3088. [Google Scholar] [CrossRef] [PubMed]
  50. Sun, C.; Liu, Q.; Shah, M.; Che, Q.; Zhang, G.; Zhu, T.; Zhou, J.; Rong, X.; Li, D. Talaverrucin A, Heterodimeric Oxaphenalenone from Antarctica Sponge-Derived Fungus Talaromyces Sp. HDN151403, Inhibits Wnt/β-Catenin Signaling Pathway. Org. Lett. 2022, 24, 3993–3997. [Google Scholar] [CrossRef]
  51. Choi, H.Y.; Ahn, J.-H.; Kwon, H.; Yim, J.H.; Lee, D.; Choi, J.-H. Citromycin Isolated from the Antarctic Marine-Derived Fungi, Sporothrix Sp., Inhibits Ovarian Cancer Cell Invasion via Suppression of ERK Signaling. Mar. Drugs. 2022, 20, 275. [Google Scholar] [CrossRef]
  52. Sun, C.; Liu, X.; Sun, N.; Zhang, X.; Shah, M.; Zhang, G.; Che, Q.; Zhu, T.; Li, J.; Li, D. Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived Aspergillus Insulicola. J. Nat. Prod. 2022, 85, 987–996. [Google Scholar] [CrossRef]
  53. Hou, Z.; Sun, C.; Chen, X.; Zhang, G.; Che, Q.; Li, D.; Zhu, T. Xanalterate A, Altertoxin VIII and IX, Perylenequinone Derivatives from Antarctica-Sponge-Derived Fungus Alternaria Sp. HDN19-690. Tetrahedron Lett. 2022, 96, 153778. [Google Scholar] [CrossRef]
Figure 1. Secondary metabolites isolated from Cladosporium cladosporioides.
Figure 1. Secondary metabolites isolated from Cladosporium cladosporioides.
Marinedrugs 21 00098 g001
Figure 2. Secondary metabolites isolated from Penicillium brevicompactun.
Figure 2. Secondary metabolites isolated from Penicillium brevicompactun.
Marinedrugs 21 00098 g002
Figure 3. Secondary metabolites isolated from Geotrichum sp.
Figure 3. Secondary metabolites isolated from Geotrichum sp.
Marinedrugs 21 00098 g003
Figure 4. Secondary metabolite isolated from Cladosporium cladosorioides.
Figure 4. Secondary metabolite isolated from Cladosporium cladosorioides.
Marinedrugs 21 00098 g004
Figure 5. Secondary metabolites isolated from Aspergillus sp.
Figure 5. Secondary metabolites isolated from Aspergillus sp.
Marinedrugs 21 00098 g005
Figure 6. Secondary metabolites isolated from Geomyces sp.
Figure 6. Secondary metabolites isolated from Geomyces sp.
Marinedrugs 21 00098 g006
Scheme 1. Proposed biosynthetic pathway to 26 and 27.
Scheme 1. Proposed biosynthetic pathway to 26 and 27.
Marinedrugs 21 00098 sch001
Scheme 2. Biomimetic synthesis of ent-Penilactone A and Penilactone B.
Scheme 2. Biomimetic synthesis of ent-Penilactone A and Penilactone B.
Marinedrugs 21 00098 sch002
Figure 7. Secondary metabolites isolated from Tridocherma asperellum.
Figure 7. Secondary metabolites isolated from Tridocherma asperellum.
Marinedrugs 21 00098 g007
Figure 8. Secondary metabolites isolated from Penicillium crustosum PRB-2.
Figure 8. Secondary metabolites isolated from Penicillium crustosum PRB-2.
Marinedrugs 21 00098 g008
Figure 9. Secondary metabolites isolated from the Antarctic fungus Oidiodendron truncatum.
Figure 9. Secondary metabolites isolated from the Antarctic fungus Oidiodendron truncatum.
Marinedrugs 21 00098 g009
Figure 10. Secondary metabolites isolated from Pseudogymnoascus sp.
Figure 10. Secondary metabolites isolated from Pseudogymnoascus sp.
Marinedrugs 21 00098 g010
Figure 11. Secondary metabolites isolated from Penicillium sp. S-1-18.
Figure 11. Secondary metabolites isolated from Penicillium sp. S-1-18.
Marinedrugs 21 00098 g011
Figure 12. Penixylarins A–D, isolated from Penicillium crestosum PRB-2 and the fungus Xylaria sp. HDN12-249.
Figure 12. Penixylarins A–D, isolated from Penicillium crestosum PRB-2 and the fungus Xylaria sp. HDN12-249.
Marinedrugs 21 00098 g012
Figure 13. Secondary metabolites isolated from Penicillium chrysogenum.
Figure 13. Secondary metabolites isolated from Penicillium chrysogenum.
Marinedrugs 21 00098 g013
Figure 14. Alkaloids isolated from Penicillium echinulatum.
Figure 14. Alkaloids isolated from Penicillium echinulatum.
Marinedrugs 21 00098 g014
Figure 15. Penicillic acid isolated from Penicillium sp. CRM-1540.
Figure 15. Penicillic acid isolated from Penicillium sp. CRM-1540.
Marinedrugs 21 00098 g015
Figure 16. Talaverrucin A isolated from Penicillium sp. CRM-1540.
Figure 16. Talaverrucin A isolated from Penicillium sp. CRM-1540.
Marinedrugs 21 00098 g016
Figure 17. Citromycin isolated from Sporothrix sp.
Figure 17. Citromycin isolated from Sporothrix sp.
Marinedrugs 21 00098 g017
Figure 18. Insucolides (D–G) isolated from Aspergillus insulicola HDN151418.
Figure 18. Insucolides (D–G) isolated from Aspergillus insulicola HDN151418.
Marinedrugs 21 00098 g018
Figure 19. Perylenequinones isolated from Aspergillus insulicola HDN151418.
Figure 19. Perylenequinones isolated from Aspergillus insulicola HDN151418.
Marinedrugs 21 00098 g019
Table 1. Secondary metabolites isolated from Chilean and Antarctic Fungi.
Table 1. Secondary metabolites isolated from Chilean and Antarctic Fungi.
CompoundsFungiRegionBioactivityReferences
1Cladosporium cladosporioidesChilean coastsNot antimicrobial activity showed[23]
2Inonotus obliquus
Geotrichum sp.
Cytotoxic activity, Lipid-peroxidation, Antioxidant activity[22,23,26]
3Penicillium brevicompactumAntibacterial activity[24]
4
5
6
7Geotrichum sp.Not tested[26]
8Scleroderma polyrizum
Geotrichum sp.
Lampteromyces japonicus
Fomes officinalis
Not tested[25,26]
9Geotrichum sp.Not tested[26]
10Geomyces sp.Not tested[27]
11Aspergillus sp.Antibacterial activity[28]
12Antitumor activity
13Vasorelaxant activity
14Aspergillus sp.Not tested[28]
15Geomyces sp.AntarcticNot antimicrobial, and antifungal
activity showed
[31,32,33,34]
16Not antimicrobial, and antifungal
activity showed
17Not antimicrobial, and antifungal
activity showed
18Antifungal activity
19Antibacterial activity
20Tridocherma asperellumNot tested[35]
21Not tested
22Not tested
23Not tested
24Not tested
25Not tested
26Penicillium crustosumNot cytotoxic activity showed[36,37]
27Inhibit nuclear factor-κB (NF-κB)
28Oidiodendron truncatum GW3-13Cytotoxic activity[38]
29
30
31No significant cytotoxic activity showed
32No significant cytotoxic activity showed
33No significant cytotoxic activity showed
34No significant cytotoxic activity showed
35Pseudogymnoascus sp.Not antimicrobial and antifungal activity showed[40]
36Not antimicrobial and antifungal activity showed
37Not antimicrobial and antifungal activity showed
38Not antimicrobial and antifungal activity showed
39Penicillium sp.AntarcticAntiproliferative effect[42]
40Not antiproliferative effect showed
41Not antiproliferative effect showed
42Not antiproliferative effect showed
43Not antiproliferative effect showed
44Not antiproliferative effect showed
45Not antiproliferative effect showed
46Not antiproliferative effect showed
47Penicillium crestosum (PRB-2)No cytotoxic and antibacterial activity showed[44]
48Antibacterial activity
49Antibacterial activity
50No cytotoxic, and antibacterial activity showed
51Penicillium chrysogenumModerate alpha glucosidase inhibition, no cytotoxic and antibacterial activity showed[47]
51aModerate alpha glucosidase inhibition, no cytotoxic and antibacterial activity showed
51bModerate alpha glucosidase inhibition, no cytotoxic and antibacterial activity showed
52aModerate alpha glucosidase inhibition, no cytotoxic and antibacterial activity showed
52bModerate alpha glucosidase inhibition, no cytotoxic and antibacterial activity showed
53Antibacterial activity
54Cytotoxic activity
55Alpha glucosidase inhibition
56Penicillium echinulatumPhotoprotective and antioxidant activity[48]
57No cytotoxic and antibacterial activity showed
58Cytotoxic activity
59Cytotoxic activity
60Penicillium sp. CRM-1540Antibacterial activity[49]
61Talaromyces sp. HDN151403Cytotoxic activity[50]
62Sporothrix sp.Cytotoxic activity[51]
63Aspergillus insulicola HDN151418No cytotoxic activity showed[52]
64No cytotoxic activity showed
65Cytotoxic activity
66Cytotoxic activity
67Alternaria sp. HDN19-690Antibacterial activity, no cytotoxic activity showed[53]
68No cytotoxic and antibacterial activity showed
69No cytotoxic and antibacterial activity showed
70No cytotoxic and antibacterial activity showed
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Arrieche, D.; Cabrera-Pardo, J.R.; San-Martin, A.; Carrasco, H.; Taborga, L. Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance. Mar. Drugs 2023, 21, 98. https://doi.org/10.3390/md21020098

AMA Style

Arrieche D, Cabrera-Pardo JR, San-Martin A, Carrasco H, Taborga L. Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance. Marine Drugs. 2023; 21(2):98. https://doi.org/10.3390/md21020098

Chicago/Turabian Style

Arrieche, Dioni, Jaime R. Cabrera-Pardo, Aurelio San-Martin, Héctor Carrasco, and Lautaro Taborga. 2023. "Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance" Marine Drugs 21, no. 2: 98. https://doi.org/10.3390/md21020098

APA Style

Arrieche, D., Cabrera-Pardo, J. R., San-Martin, A., Carrasco, H., & Taborga, L. (2023). Natural Products from Chilean and Antarctic Marine Fungi and Their Biomedical Relevance. Marine Drugs, 21(2), 98. https://doi.org/10.3390/md21020098

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop